Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR study.

Locally-advanced stage Minor salivary gland Salivary gland carcinoma Tongue Totalglossectomy

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
20 Oct 2024
Historique:
received: 06 05 2024
revised: 30 09 2024
accepted: 04 10 2024
medline: 22 10 2024
pubmed: 22 10 2024
entrez: 21 10 2024
Statut: aheadofprint

Résumé

Salivary carcinomas of the tongue represent a therapeutic challenge as their radical excision is particularly mutilating. We aimed to study the oncologic and functional outcomes of advanced stages salivary carcinomas of the tongue. This retrospective multicentric study, based on the French national network on rare head and neck cancers (REFCOR), included all patients with a T3-T4 salivary carcinoma of the tongue, diagnosed between January 2009 and December 2018. In total, 47 patients were included, of which 44.7 % underwent surgery. Histologies were mostly adenoid cystic carcinomas (61.7 %), followed by other adenocarcinomas (27.7 %) and mucoepidermoid carcinomas (10.6 %). Median follow-up duration was 63.9 months. In multivariable analysis, surgery was significantly associated with better Recurrence-Free Survival (HR = 0.23, 95 %CI [0.09;0.55]) and Local/Regional Recurrence-Free Survival (HR = 0.31, 95 %CI [0.10;0.95]). The rate of distant metastasis at the end of follow-up was 61.9 % in the surgical group and 57.7 % in the non-surgical group. The Distant Metastasis Free Survival was 54.9 % [38.3;68.7], without statistical difference between both groups. There were similar rates of definitive gastrostomies but the rate of normal oral diet at the last follow-up seemed higher in the surgery group (38.1 % vs 15.4 %). Radical surgery in that population mainly aims to improve local/regional control, which may result in better long-term swallowing functions. About half of these tumors may be associated with occult distant metastasis at initial presentation. More studies are warranted to establish the role of postoperative RT and non-surgical treatment with concurrent CRT.

Identifiants

pubmed: 39432991
pii: S1368-8375(24)00390-7
doi: 10.1016/j.oraloncology.2024.107072
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107072

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Valentine Poissonnet (V)

Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Larrey Hospital, Toulouse, France. Electronic address: valentine.poissonnet@gmail.com.

Emilien Chabrillac (E)

Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Larrey Hospital, Toulouse, France.

Emmanuelle Uro-Coste (E)

Department of Anatomical Pathology, University Cancer Institute Toulouse, Toulouse France.

Virginie Woisard (V)

Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Larrey Hospital, Toulouse, France.

Antoine Moya-Plana (A)

Head and Neck Oncology Department, Gustave-Roussy Institute, Villejuif, France.

Florent Espitalier (F)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Nantes, France.

Joel Castelli (J)

Department of Radiation Oncology, Centre Eugene Marquis, Rennes, France.

Thibault Dedieu (T)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Strasbourg, France.

Sébastien Salas (S)

AP-HM, Aix-Marseille University, Department of Medical Oncology, Marseille, France.

Renaud Garrel (R)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Montpellier, France.

Robin Baudouin (R)

Otolaryngology, Head and Neck Surgery Department, Foch Hospital, Paris, France.

Gilles Poissonnet (G)

Otolaryngology, Head and Neck Surgery Department, Head and Neck University Institute, Nice, France.

Claire Castain (C)

Department of Anatomical Pathology, Bordeaux University Hospital-CHU, F-33000, Bordeaux, France.

Jonathan Barbut (J)

Otolaryngology, Head and Neck Surgery Department, Hospital of Toulon, France.

Haitham Mirghani (H)

Otolaryngology, Head and Neck Surgery Department, George Pompidou European Hospital, Paris, France.

Diane Evrard (D)

Otolaryngology, Head and Neck Surgery Department, Bichat Hospital, Paris, France.

Olivier Bouchain (O)

Head and Neck Surgery Department, CHU Sart Tilman, University Liege, Belgium.

Jean Paul Marie (JP)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Rouen, France.

Hélène Orliac (H)

Department of Radiation Therapy, University Hospital of Limoges, France.

Philippe Ceruse (P)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Lyon, France.

Xavier Dufour (X)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Poitiers, France.

Esteban Brenet (E)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Reims, France.

Audrey Rambeau (A)

Oncology Department, François Baclesse Centre, Caen, France.

Philippe Herman (P)

Otolaryngology, Head and Neck Surgery Department, Lariboisière Hospital, 2 rue Ambroise Paré, 75010 Paris, France.

Yazan Abu Shama (Y)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Nancy, France.

Chloé Bertolus (C)

Department of Oral and Maxillo-Facial Surgery, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, France.

Sarah Atallah (S)

Head and Neck Surgery Department, Tenon Hospital, APHP, Sorbonne University, Paris, France.

Sylvain Morinière (S)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Tours, France.

Christian Righini (C)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Grenoble, France.

François Mouawad (F)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Lille, France.

Suzy Duflo (S)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Point-à-Pitre, France.

Bertille Segier (B)

Statistical Department, Institut Claudius Regaud, University Institute of Cancer, Toulouse, France.

Sébastien Vergez (S)

Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Larrey Hospital, Toulouse, France.

Classifications MeSH